Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
LACOSAMIDE
Pharmascience International Limited Julia House, Themistokli Dervi, 3 P.C. 1066 NICOSIA (CYPRUS)
N03AX18
LACOSAMIDE
Filmomhulde tablet
CELLULOSE, MICROKRISTALLIJN (E 460) ; CROSPOVIDON (E 1202) ; HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463) ; HYPROLOSE (E 463) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; IJZEROXIDE ZWART (E 172) ; MACROGOL 3350 ; MAGNESIUMSTEARAAT (E 470b) ; POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203) ; SILICIUMDIOXIDE (E 551) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171),
Oraal gebruik
Lacosamide
Hulpstoffen: CELLULOSE, MICROKRISTALLIJN (E 460); CROSPOVIDON (E 1202); HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463); HYPROLOSE (E 463); IJZEROXIDE GEEL (E 172); IJZEROXIDE ROOD (E 172); IJZEROXIDE ZWART (E 172); MACROGOL 3350; MAGNESIUMSTEARAAT (E 470b); POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203); SILICIUMDIOXIDE (E 551); TALK (E 553 B); TITAANDIOXIDE (E 171);
2018-04-25
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT LACOSAMIDE PHARMASCIENCE INTERNATIONAL LTD 50 MG FILMOMHULDE TABLETTEN LACOSAMIDE PHARMASCIENCE INTERNATIONAL LTD 100 MG FILMOMHULDE TABLETTEN LACOSAMIDE PHARMASCIENCE INTERNATIONAL LTD 150 MG FILMOMHULDE TABLETTEN LACOSAMIDE PHARMASCIENCE INTERNATIONAL LTD 200 MG FILMOMHULDE TABLETTEN Lacosamide READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Lacosamide Pharmascience International LTD is and what it is used for 2. What you need to know before you take Lacosamide Pharmascience International LTD 3. How to take Lacosamide Pharmascience International LTD 4. Possible side effects 5. How to store Lacosamide Pharmascience International LTD 6. Contents of the pack and other information 1. WHAT LACOSAMIDE PHARMASCIENCE INTERNATIONAL LTD IS AND WHAT IT IS USED FOR WHAT LACOSAMIDE PHARMASCIENCE INTERNATIONAL LTD IS Lacosamide Pharmascience International LTD contains lacosamide. This belongs to a group of medicines called “antiepileptic medicines”. These medicines are used to treat epilepsy. You have been given this medicine to lower the number of fits (seizures) you have. WHAT LACOSAMIDE PHARMASCIENCE INTERNATIONAL LTD IS USED FOR Lacosamide Pharmascience International LTD is used in adults, adolescents and children aged 4 years and older. It is used to treat a certain type of epilepsy called “partial-onset seizure with or without secondary generalisation”. In this type of epilepsy, fits first affect only one side of the brain. Lees het volledige document
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lacosamide Pharmascience International LTD 50 mg filmomhulde tabletten Lacosamide Pharmascience International LTD 100 mg filmomhulde tabletten Lacosamide Pharmascience International LTD 150 mg filmomhulde tabletten Lacosamide Pharmascience International LTD 200 mg filmomhulde tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 50 mg lacosamide. Each film-coated tablet contains 100 mg lacosamide. Each film-coated tablet contains 150 mg lacosamide. Each film-coated tablet contains 200 mg lacosamide. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Pink colored, oval, biconvex, coated tablets, debossed with “LAC” on one side and ‘50’ on the other side. Approximate dimension of the tablets: Length=10.30 mm; Width=4.80 mm; Thickness=3.30 mm. Yellow colored, oval, biconvex, coated tablets, debossed with “LAC” on one side and ‘100’ on the other side. Approximate dimension of the tablets: Length=13.10 mm; Width=6.00 mm; Thickness=4.10 mm Salmon colored, oval, biconvex, coated tablets, debossed with”LAC” on one side and ‘150’ on the other side. Aproximate dimension of the tablets: Length=15.00 mm; Width=7.00 mm; Thickness=4.60 mm Blue colored, oval, biconvex, coated tablets debossed with “LAC” on one side and ‘200’ on the other side. Approximate dimension of the tablets: Length=16.50 mm; Width=7.60 mm; Thickness=5.30 mm 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lacosamide Pharmascience International LTD is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Lacosamide must be taken twice a day (usually once in the morning and once in the evening). Lacosamide may be taken with or without food. If a dose is missed, the patient should be in Lees het volledige document